control
crystal
crystallization
crystals
delivery
development
drug
engineering
equipment
high
inhaled
manufacture
manufacturing
medicines
oxford
particle
particles
pharmaceutical
power
process
processing
product
products
proprietary
prosonix
respiratory
scale
science
size
technologies
technology
ultrasonic
ultrasound
used
using
| Partnered Development Pipeline |
 |
 |
 |
| Friday, 05 March 2010 00:00 |
|
Prosonix welcomes enquiries from all parties interested in licensing and co-development opportunities. Please contact David Hipkiss CEO or Contact us Partnered development pipeline
             |
| Last Updated on Thursday, 30 June 2011 10:11 |
Navigation
Latest News
03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest
